In this study, we investigate the role of BCAAs metabolism in the progression of NAFLD and the protective effect of BCATc Inhibitor 2 against NAFLD with its underlying mechanism. Here, BCAT1 is linked to metabolic dysfunction-associated steatotic liver disease.